Part 9/11:
Health and science updates include new systemic approaches to lowering drug prices and improving public health. President Trump’s administration has engaged pharmaceutical companies like Pfizer to reduce the costs of prescription drugs to Americans, aligning prices with those overseas. This effort leverages tariffs and regulatory tools to promote fairness and transparency, aiming for broader access to affordable medication.